- Home
- CLOV
as 08-29-2025 10:31am EST
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | JERSEY CITY |
| Market Cap: | 1.5B | IPO Year: | N/A |
| Target Price: | $4.37 | AVG Volume (30 days): | 8.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.12 - $4.87 | Next Earning Date: | 08-05-2025 |
| Revenue: | $1,607,900,000 | Revenue Growth: | 22.12% |
| Revenue Growth (this year): | 39.93% | Revenue Growth (next year): | 27.06% |
Stock Insider Trading Activity of Clover Health Investments Corp. (CLOV)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Loengard Anna U | CLOV | N/A | Aug 13 '25 | Buy | $2.59 | 26,500 | $68,755.00 | 27,600 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Jun 17 '25 | Sell | $2.86 | 20,450 | $58,487.00 | 3,196,401 |
Latest Clover Health Investments Corp. News
CLOV Breaking Stock News: Dive into CLOV Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 months ago
Organogenesis Holdings Leads The Charge With 2 Other Promising Penny Stocks
Simply Wall St.
3 months ago
Oncology Institute And 2 Other Promising Penny Stocks To Watch
Simply Wall St.
4 months ago
Clover Health Investments And 2 Other Growth Stocks With Strong Insider Confidence
Simply Wall St.
4 months ago
Clover Health Investments, Corp.'s (NASDAQ:CLOV) market cap rose US$220m last week; individual investors who hold 59% profited and so did insiders
GlobeNewswire
4 months ago
Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance
GuruFocus.com
4 months ago
Clover Health Investments Corp (CLOV) Q1 2025 Earnings Report Preview: What To Look For
GlobeNewswire
4 months ago
Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure
GlobeNewswire
4 months ago
Clover Health Announces Changes to Board of Directors
Compare CLOV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLOV Clover Health Investments Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.